Integrative Research
Integrative Research supports cancer researchers studying evidence-based complementary therapies alongside conventional treatment to manage symptoms and side effects and improve patients’ quality of life.
Browse similar grants
Funder: Gateway for Cancer Research
Due Dates: November 6, 2026 (LOI; tentative) | As specified in invitation (full application)
Funding Amounts: Not specified
Summary: Supports research pairing conventional cancer therapies with evidence-based complementary therapies to improve quality of life during treatment.
Description
Gateway for Cancer Research funds integrative oncology research that pairs conventional cancer therapies with evidence-based complementary therapies. The program focuses on managing symptoms and side effects during treatment and improving patients’ quality of life while treatment is underway.
Gateway funds patient-centered, early-phase cancer clinical trials. Its broader research priorities include mitigating treatment toxicity and studying integrative medicine alongside other treatment-based approaches. For this program, the emphasis is on examining how complementary therapies can be used together with conventional treatment to address patients’ experience of cancer care.
